Welcome to LookChem.com Sign In|Join Free

CAS

  • or

111300-06-2

Post Buying Request

111300-06-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

111300-06-2 Usage

Description

BOC-TRANS-4-AMINOCYCLOHEXANOL, also known as trans-4-(Boc-amino)cyclohexanol, is an organic compound that serves as a crucial intermediate in the synthesis of various biologically active molecules. It is characterized by its unique chemical structure, which includes a cyclohexanol ring with an amino group and a Boc-protecting group. BOC-TRANS-4-AMINOCYCLOHEXANOL plays a significant role in the development of potent activators for Heme-regulated inhibitor kinase, a protein kinase involved in the regulation of hemoglobin synthesis.

Uses

Used in Pharmaceutical Industry:
BOC-TRANS-4-AMINOCYCLOHEXANOL is used as an intermediate in the synthesis of potent activators for Heme-regulated inhibitor kinase (HRI kinase). The application reason is that it serves as a key building block in the development of these activators, which have potential therapeutic applications in the treatment of various diseases and conditions related to hemoglobin synthesis and regulation.
In the synthesis of HRI kinase activators, BOC-TRANS-4-AMINOCYCLOHEXANOL provides a versatile platform for the introduction of various functional groups and modifications, allowing for the optimization of the activator's potency, selectivity, and pharmacokinetic properties. This makes it a valuable compound in the design and development of novel therapeutic agents targeting HRI kinase.
Furthermore, the compound's unique chemical structure and reactivity also make it a potential candidate for use in other areas of pharmaceutical research, such as the development of inhibitors or modulators for other protein kinases or enzymes. This could lead to the discovery of new drugs for the treatment of various diseases, including cancer, neurological disorders, and inflammatory conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 111300-06-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,3,0 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 111300-06:
(8*1)+(7*1)+(6*1)+(5*3)+(4*0)+(3*0)+(2*0)+(1*6)=42
42 % 10 = 2
So 111300-06-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H21NO3/c1-11(2,3)15-10(14)12-8-4-6-9(13)7-5-8/h8-9,13H,4-7H2,1-3H3,(H,12,14)/t8-,9+

111300-06-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H62802)  trans-4-(Boc-amino)cyclohexanol, 97%   

  • 111300-06-2

  • 25g

  • 341.0CNY

  • Detail
  • Alfa Aesar

  • (H62802)  trans-4-(Boc-amino)cyclohexanol, 97%   

  • 111300-06-2

  • 100g

  • 1090.0CNY

  • Detail

111300-06-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Boc-Trans-4-Aminocyclohexanol

1.2 Other means of identification

Product number -
Other names BOC-TRANS-4-AMINOCYCLOHEXANOL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:111300-06-2 SDS

111300-06-2Relevant articles and documents

Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinase

Chen, Ting,Takrouri, Khuloud,Hee-Hwang, Sung,Rana, Sandeep,Yefidoff-Freedman, Revital,Halperin, Jose,Natarajan, Amarnath,Morisseau, Christophe,Hammock, Bruce,Chorev, Michael,Aktas, Bertal H.

, p. 9457 - 9470 (2013)

Heme-regulated inhibitor kinase (HRI), a eukaryotic translation initiation factor 2 alpha (eIF2α) kinase, plays critical roles in cell proliferation, differentiation, and adaptation to cytoplasmic stress. HRI is also a critical modifier of hemoglobin disorders such as β-thalassemia. We previously identified N,N′-diarylureas as potent activators of HRI suitable for studying the biology of this important kinase. To expand the repertoire of chemotypes that activate HRI, we screened a ~1900 member N,N′-disubstituted urea library in the surrogate eIF2α phosphorylation assay, identifying N-aryl,N′-cyclohexylphenoxyurea as a promising scaffold. We validated hit compounds as a bona fide HRI activators in secondary assays and explored the contributions of substitutions on the N-aryl and N′-cyclohexylphenoxy groups to their activity by studying focused libraries of complementing analogues. We tested these N-aryl,N′- cyclohexylphenoxyureas in the surrogate eIF2α phosphorylation and cell proliferation assays, demonstrating significantly improved bioactivities and specificities. We consider these compounds to represent lead candidates for the development of potent and specific HRI activators.

ALKYNYL QUINAZOLINE COMPOUNDS

-

Paragraph 1094, (2021/02/19)

The present disclosure relates to compounds of Formula (I'): and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparation these compounds, compositions comprising these compounds, and methods of using them in the prevention or treatment of abnormal cell growth in mammals, especially humans.

Catalytic Transfer Hydrogenation of Arenes and Heteroarenes

Gelis, Coralie,Heusler, Arne,Nairoukh, Zackaria,Glorius, Frank

supporting information, p. 14090 - 14094 (2020/10/19)

Transfer hydrogenation reactions are of great interest to reduce diverse molecules under mild reaction conditions. To date, this type of reaction has only been successfully applied to alkenes, alkynes and polarized unsaturated compounds such as ketones, imines, pyridines, etc. The reduction of benzene derivatives by transfer hydrogenation has never been described, which is likely due to the high energy barrier required to dearomatize these compounds. In this context, we have developed a catalytic transfer hydrogenation reaction for the reduction of benzene derivatives and heteroarenes to form complex 3-dimensional scaffolds bearing various functional groups at room temperature without needing compressed hydrogen gas.

Photoinduced Deoxygenative Borylations of Aliphatic Alcohols

Wu, Jingjing,B?r, Robin M.,Guo, Lin,Noble, Adam,Aggarwal, Varinder K.

supporting information, p. 18830 - 18834 (2019/11/22)

A photochemical method for converting aliphatic alcohols into boronic esters is described. Preactivation of the alcohol as a 2-iodophenyl-thionocarbonate enables a novel Barton–McCombie-type radical deoxygenation that proceeds efficiently with visible light irradiation and without the requirement for a photocatalyst, a radical initiator, or tin or silicon hydrides. The resultant alkyl radical is intercepted by bis(catecholato)diboron, furnishing boronic esters from a diverse range of structurally complex alcohols.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 111300-06-2